Literature DB >> 22270329

Implication of the miR-184 and miR-204 competitive RNA network in control of mouse secondary cataract.

Andrea Hoffmann1, Yusen Huang, Rinako Suetsugu-Maki, Carol S Ringelberg, Craig R Tomlinson, Katia Del Rio-Tsonis, Panagiotis A Tsonis.   

Abstract

The high recurrence rate of secondary cataract (SC) is caused by the intrinsic differentiation activity of residual lens epithelial cells after extra-capsular lens removal. The objective of this study was to identify changes in the microRNA (miRNA) expression profile during mouse SC formation and to selectively manipulate miRNA expression for potential therapeutic intervention. To model SC, mouse cataract surgery was performed and temporal changes in the miRNA expression pattern were determined by microarray analysis. To study the potential SC counterregulative effect of miRNAs, a lens capsular bag in vitro model was used. Within the first 3 wks after cataract surgery, microarray analysis demonstrated SC-associated expression pattern changes of 55 miRNAs. Of the identified miRNAs, miR-184 and miR-204 were chosen for further investigations. Manipulation of miRNA expression by the miR-184 inhibitor (anti-miR-184) and the precursor miRNA for miR-204 (pre-miR-204) attenuated SC-associated expansion and migration of lens epithelial cells and signs of epithelial to mesenchymal transition such as α-smooth muscle actin expression. In addition, pre-miR-204 attenuated SC-associated expression of the transcription factor Meis homeobox 2 (MEIS2). Examination of miRNA target binding sites for miR-184 and miR-204 revealed an extensive range of predicted target mRNA sequences that were also a target to a complex network of other SC-associated miRNAs with possible opposing functions. The identification of the SC-specific miRNA expression pattern together with the observed in vitro attenuation of SC by anti-miR-184 and pre-miR-204 suggest that miR-184 and miR-204 play a significant role in the control of SC formation in mice that is most likely regulated by a complex competitive RNA network.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22270329      PMCID: PMC3356433          DOI: 10.2119/molmed.2011.00463

Source DB:  PubMed          Journal:  Mol Med        ISSN: 1076-1551            Impact factor:   6.354


  74 in total

Review 1.  miRNAs: roles and clinical applications in vascular disease.

Authors:  Md Saha Jamaluddin; Sarah M Weakley; Lidong Zhang; Panagiotis Kougias; Peter H Lin; Qizhi Yao; Changyi Chen
Journal:  Expert Rev Mol Diagn       Date:  2011-01       Impact factor: 5.225

2.  MiR-30 family and EMT in human fetal pancreatic islets.

Authors:  Sabire Ozcan
Journal:  Islets       Date:  2009 Nov-Dec       Impact factor: 2.694

3.  The miR-30 family microRNAs confer epithelial phenotype to human pancreatic cells.

Authors:  Mugdha V Joglekar; Deepak Patil; Vinay M Joglekar; G V Rao; D Nageshwar Reddy; Sasikala Mitnala; Yogesh Shouche; Anandwardhan A Hardikar
Journal:  Islets       Date:  2009 Sep-Oct       Impact factor: 2.694

4.  Redefining microRNA targets.

Authors:  Hervé Seitz
Journal:  Curr Biol       Date:  2009-04-16       Impact factor: 10.834

Review 5.  Posterior capsule opacification.

Authors:  I Michael Wormstone; Lixin Wang; Christopher S C Liu
Journal:  Exp Eye Res       Date:  2008-10-29       Impact factor: 3.467

Review 6.  Post-transcriptional gene-expression regulation by micro RNA (miRNA) network in renal disease.

Authors:  Tamás Kaucsár; Zsuzsanna Rácz; Péter Hamar
Journal:  Adv Drug Deliv Rev       Date:  2010-10-19       Impact factor: 15.470

7.  miR-133 and miR-30 regulate connective tissue growth factor: implications for a role of microRNAs in myocardial matrix remodeling.

Authors:  Rudy F Duisters; Anke J Tijsen; Blanche Schroen; Joost J Leenders; Viola Lentink; Ingeborg van der Made; Veronica Herias; Rick E van Leeuwen; Mark W Schellings; Paul Barenbrug; Jos G Maessen; Stephane Heymans; Yigal M Pinto; Esther E Creemers
Journal:  Circ Res       Date:  2008-12-18       Impact factor: 17.367

Review 8.  TGF beta in fibroproliferative diseases in the eye.

Authors:  Shizuya Saika; Osamu Yamanaka; Yuka Okada; Sai-Ichi Tanaka; Takeshi Miyamoto; Takayoshi Sumioka; Ai Kitano; Kumi Shirai; Kazuo Ikeda
Journal:  Front Biosci (Schol Ed)       Date:  2009-06-01

9.  miRNeye: a microRNA expression atlas of the mouse eye.

Authors:  Marianthi Karali; Ivana Peluso; Vincenzo A Gennarino; Marchesa Bilio; Roberta Verde; Giampiero Lago; Pascal Dollé; Sandro Banfi
Journal:  BMC Genomics       Date:  2010-12-20       Impact factor: 3.969

Review 10.  MicroRNA and cancer--focus on apoptosis.

Authors:  Yu Wang; Caroline G L Lee
Journal:  J Cell Mol Med       Date:  2009-01       Impact factor: 5.310

View more
  15 in total

1.  Expression of the microRNAs hsa-miR-15a and hsa-miR-16-1 in lens epithelial cells of patients with age-related cataract.

Authors:  Yuanbin Li; Shujun Liu; Fenglan Zhang; Pengfei Jiang; Xinyi Wu; Yan Liang
Journal:  Int J Clin Exp Med       Date:  2015-02-15

Review 2.  TRPM3_miR-204: a complex locus for eye development and disease.

Authors:  Alan Shiels
Journal:  Hum Genomics       Date:  2020-02-18       Impact factor: 4.639

Review 3.  Non-coding RNAs in the development of sensory organs and related diseases.

Authors:  Ivan Conte; Sandro Banfi; Paola Bovolenta
Journal:  Cell Mol Life Sci       Date:  2013-04-16       Impact factor: 9.261

4.  MiRNA-26b inhibits the proliferation, migration, and epithelial-mesenchymal transition of lens epithelial cells.

Authors:  Ning Dong; Bing Xu; Silvia R Benya; Xin Tang
Journal:  Mol Cell Biochem       Date:  2014-07-26       Impact factor: 3.396

5.  miR-184 exhibits angiostatic properties via regulation of Akt and VEGF signaling pathways.

Authors:  Jong Kook Park; Han Peng; Wending Yang; Julia Katsnelson; Olga Volpert; Robert M Lavker
Journal:  FASEB J       Date:  2016-10-07       Impact factor: 5.191

6.  MicroRNA-486-5p suppresses TGF-β2-induced proliferation, invasion and epithelial-mesenchymal transition of lens epithelial cells by targeting Smad2.

Authors:  Bei Liu; Jianhua Sun; Xiaoqin Lei; Zhongqiao Zhu; Cheng Pei; Li Qin
Journal:  J Biosci       Date:  2017-12       Impact factor: 1.826

7.  Expression of lens-related microRNAs in transparent infant lenses and congenital cataract.

Authors:  Chang-Rui Wu; Min Ye; Li Qin; Yue Yin; Cheng Pei
Journal:  Int J Ophthalmol       Date:  2017-03-18       Impact factor: 1.779

8.  Development of Electrochemical Biosensor for miR204-Based Cancer Diagnosis.

Authors:  Shilpa Gundagatti; Sudha Srivastava
Journal:  Interdiscip Sci       Date:  2022-04-26       Impact factor: 2.233

Review 9.  MicroRNAs: new players in cataract.

Authors:  Xin Yu; Heyi Zheng; Matthew Tv Chan; William Ka Kei Wu
Journal:  Am J Transl Res       Date:  2017-09-15       Impact factor: 4.060

10.  Pax6 regulates gene expression in the vertebrate lens through miR-204.

Authors:  Ohad Shaham; Karen Gueta; Eyal Mor; Pazit Oren-Giladi; Dina Grinberg; Qing Xie; Ales Cvekl; Noam Shomron; Noa Davis; Maya Keydar-Prizant; Shaul Raviv; Metsada Pasmanik-Chor; Rachel E Bell; Carmit Levy; Raffaella Avellino; Sandro Banfi; Ivan Conte; Ruth Ashery-Padan
Journal:  PLoS Genet       Date:  2013-03-14       Impact factor: 5.917

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.